- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Punctate Palmoplantar Keratoderma Type 1 in Taiwan
Total 28 results
-
Chang Gung UniversityChang Gung Memorial HospitalRecruiting
-
Chang Gung UniversityChang Gung Memorial HospitalRecruitingType 1 Diabetes MellitusTaiwan
-
Chang Gung Memorial HospitalCompletedThe Genetic Variation of Type 1 DiabetesTaiwan
-
National Taiwan University HospitalUnknown
-
China Medical University HospitalCompleted
-
National Taiwan University HospitalUnknownType 1 Diabetes MellitusTaiwan
-
National Taiwan University HospitalCompletedType 1 Diabetes MellitusTaiwan
-
National Taipei University of Nursing and Health...CompletedType 1 Diabetes | Self-management | HbA1cTaiwan
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Taiwan
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
Second Xiangya Hospital of Central South UniversityRecruitingDiabetes | Type1diabetesChina
-
Eli Lilly and CompanyCompletedDiabetes | Type 1 DiabetesUnited States, Taiwan, Japan, Poland, Argentina, Slovakia, Puerto Rico
-
Eli Lilly and CompanyAlkermes, Inc.Completed
-
Second Xiangya Hospital of Central South UniversityRecruiting
-
BayerRecruitingChronic Kidney Disease | Type 1 Diabetes MellitusUnited Kingdom, United States, Korea, Republic of, Denmark, Germany, Italy, China, Spain, Canada
-
Tibotec Pharmaceuticals, IrelandCompletedHIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital with Nanjing Medical University; Beijing Hospital and other collaboratorsCompletedDiabetes Mellitus, Type 1China
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, Spain, Taiwan, Belgium, United Kingdom, Germany, Canada, Australia, Finland, Netherlands, Poland, France, Denmark, Norway, Sweden, Austria, Czechia
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Chronic Obstructive Pulmonary DiseaseSlovakia, Argentina, India, Turkey, Romania, Taiwan, Thailand
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Israel, Italy, Japan, Russian Federation, Canada, Austria, Taiwan, Serbia, Germany, Bulgaria, Puerto Rico
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States, Taiwan, Australia
-
Epizyme, Inc.CompletedB-cell Lymphomas (Phase 1) | Advanced Solid Tumors (Phase 1) | Diffuse Large B-cell Lymphoma (Phase 2) | Follicular Lymphoma (Phase 2) | Transformed Follicular Lymphoma | Primary Mediastinal Large B-Cell LymphomaAustralia, Canada, France, Germany, Italy, Poland, Taiwan, Ukraine, United Kingdom, United States
-
ActelionCompletedGaucher Disease Type 1United States, Taiwan, Canada, Spain, Australia, France, Brazil, Hungary, Czechia, Germany, Italy, Netherlands, United Kingdom
-
Changlin MeiThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsCompletedPolycystic Kidney, Type 1 Autosomal Dominant DiseaseChina
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus - Type 1United States, France, United Kingdom, Germany, Taiwan, Spain, Argentina, Chile, Malaysia, Panama, Romania, South Africa, Thailand, Brazil, Puerto Rico, Austria, Hungary, Australia, Guatemala
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingUnresectable Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | Metastatic Papillary Renal Cell Carcinoma | Locally Advanced Papillary Renal Cell CarcinomaUnited States, Canada